# Oliceridine-Enhanced Analgesia and Recovery: A G-Protein Biased μ-Opioid Study

> **NCT06409689** · NA · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Postoperative Analgesia

## Interventions

- **DRUG:** Oliceridine fumarate low dose
- **DRUG:** Oliceridine fumarate high dose
- **DRUG:** Oliceridine fumarate moderate dose
- **DRUG:** morphine

## Key facts

- **NCT ID:** NCT06409689
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06409689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06409689, "Oliceridine-Enhanced Analgesia and Recovery: A G-Protein Biased μ-Opioid Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06409689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*